1Stein-Oakley AN,Maguire JA,Dowling J,et al.Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulosclerosis.Kidncy Int,1997,51:195
2Sato H,Iwano M,Akai Y,et al.Increased excretion of urinary transforming growth factor beta 1 in patients with diabetic nephropathy.Am J Nephrol,1998,18(6):490
3Dominguez GC,Costa RS,Dantas M,et al.Transforming growth factor beta(TGF beta)activity in urine of patients with glomerulonephritis.Braz J Med Biol Res,1995,28(10):1061
4Kanai H,Mitsuhashi,Ono K,et al.Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.Nephron,1994,66:391
5Ellis D,Forrest KY,Erbey J,et al.Urinary measurement of transforming growth factor-beta an type Ⅳ collagen as new markers of renal injury application in diabetic nephropathy.Clin Chem,1998,44(5):950
6Sharma K,Ziyadeh FN,Alzahabi B,et al.Increased renal production of transforming growth factor-beta 1 in patients with type Ⅱ diabetes.Diabetes,1997,46(5):854
7Noh JW,Wiggins R,Phan SH,et al.Urine TGF-β activity is related to degree of scarring in crescentic nephritis in the rabbit.Nephron,1993,63:73
8Wolf G,Ziyadeh FN.Molecular mechanisms of diabetic renal hypertrophy.Kidney Int,1999,56(2):393
9Waldher R,Noronha IL,Niemir Z,et al.Expression of cytokines and growth factors in human glomerulonephritis.Pediatr Nephrol,1993,7:471
10Murakami K,Takemura T,Satoshi Hino,et al.Urinary transforming growth factor-β in patients with glomerular diseases.Pediatr Nephrol,1997,11:334
4Churg J, Benstein J, Glassock R J. Renal Disease:Classification and atlas of glonerular disease[M]. Tokyo:lgakushoin, 1995:4-5.
5National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease:evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002, 39:S1-266.
6Yamamoto T, Noble N A, Cohen A H, et al. Expression of transforming growth factor-β isoforms in human glomerular disease [J]. Kidney Int, 1996, 49:461.
7Gyu T S, Seung J K, Kyoung A M, et al. ACE inhibitors attenuate expression of renal TGF-β in humans[J]. Am J Kidney Dis, 2000, 36:894-902.
8Fortune F, Courteau M, Williams D G, et al. T and B cell responsesfollowing immunization with tetanus toxoid in IgA nephropathy [J]. Clin Exp Immunol, 1992, 88:62-67.
9Toyabe S, Harada W, Uchiyama M. Oligoclonally expanding gam madelta T lymphocytes induce IgA switching in IgA nephropathy[J]. Clin Exp Immunol, 2001, 124:110-117.
10Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome[J]. Semin Nephrol, 2004, 24:179-196.
